Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Award ceiling
- up to $750,000
- Closes
- Feb 10, 2027
- Last verified
- 2026-10-26
Awards up to $750,000 per recipient for city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, others (see text field entitled "additional information on eligibility" for clarification), private institutions of higher education, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, special district governments, state governments, closing Feb 10, 2027.
In one sentence
Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) awards up to $750,000 per recipient, open to city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal…
- Program pool (total)
- $4,800,000Total across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- $750,000
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Feb 10, 2027
- Deadline type
- Fixed date
- Opens
- Jun 16, 2026
- Status
- Open
- Eligible entities
- City or township governments · County governments · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · State governments
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- digestive and liver diseases research
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Who can apply?
+5more
, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governmentsNot confirmed
Source field: applicant size limitRefer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Only institutions at which there is a strong ongoing base of digestive and/or liver diseases-relevant research that relates to the…
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
What can the money be used for?
1 categoryThe source’s own spending categories, and what is not parsed.
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
Who has received this funding?
9106 awardsAwards on file for this programme, counted rather than modelled.
9106 prior awards on file for this programme, largest first. Every row comes from the funder's own award listing; nothing here is estimated.
| Recipient | State | Amount | Fiscal year |
|---|---|---|---|
| THE MEDICAL UNIVERSITY OF SOUTH CAROLINA | Not stated | $324,000 | 2024 |
| REVEL PHARMACEUTICALS INC. | Not stated | $323,833 | 2024 |
| INLIGHTA BIOSCIENCES L.L.C. | Not stated | $323,743 | 2024 |
| UNIVERSITY OF SOUTH FLORIDA | Not stated | $323,499 | 2024 |
| THE MEDICAL UNIVERSITY OF SOUTH CAROLINA | Not stated | $323,390 | 2025 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | Not stated | $323,000 | 2021 |
| UNIVERSITY OF UTAH | Not stated | $321,828 | 2025 |
| BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | Not stated | $320,796 | 2022 |
| VANDERBILT UNIVERSITY | Not stated | $320,762 | 2024 |
| UNIVERSITY OF OKLAHOMA | Not stated | $320,273 | 2025 |
| REGENTS OF THE UNIVERSITY OF MINNESOTA | Not stated | $319,550 | 2025 |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | Not stated | $318,816 | 2025 |
| LUTHERAN UNIVERSITY ASSOCIATION INC | Not stated | $318,554 | 2024 |
| DOLOR THERAPEUTICS, INC. | Not stated | $318,488 | 2024 |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | Not stated | $318,476 | 2025 |
| UNIVERSITY OF TEXAS AT AUSTIN | Not stated | $316,969 | 2021 |
| NEW YORK UNIVERSITY | Not stated | $316,385 | 2025 |
| DRIVE MEDICAL, INC. | Not stated | $315,747 | 2025 |
| VELUM INC | Not stated | $315,342 | 2025 |
| WASHINGTON UNIVERSITY, THE | Not stated | $315,000 | 2020 |
| ANGIOTENSIN THERAPEUTICS INC | Not stated | $314,355 | 2025 |
| CEROVATIONS LLC | Not stated | $314,354 | 2020 |
| MINNESOTA HEALTHSOLUTIONS CORPORATION | Not stated | $314,279 | 2025 |
| UNLOCKED LABS INC. | Not stated | $314,249 | 2023 |
| VIVONICS INC | Not stated | $314,041 | 2023 |
| THE REGENTS OF THE UNIVERSITY OF COLORADO | Not stated | $314,000 | 2024 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | Not stated | $313,872 | 2023 |
| THE REGENTS OF THE UNIVERSITY OF COLORADO | Not stated | $313,721 | 2023 |
| THE JOHNS HOPKINS UNIVERSITY | Not stated | $312,739 | 2025 |
| UNIVERSITY OF CALIFORNIA, LOS ANGELES | Not stated | $312,497 | 2025 |
| ANXOMICS LLC | Not stated | $312,492 | 2024 |
| SOJOURN MEDTECH LLC | Not stated | $312,088 | 2023 |
| CHILDREN'S HOSPITAL CORPORATION, THE | Not stated | $311,520 | 2020 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | Not stated | $311,120 | 2020 |
| PENNINGTON BIOMEDICAL RESEARCH CENTER | Not stated | $311,001 | 2024 |
| THE REGENTS OF THE UNIVERSITY OF COLORADO | Not stated | $311,000 | 2020 |
| ISLEX THERAPEUTICS, LLC | Not stated | $310,897 | 2025 |
| EVINCIS BIO, INC. | Not stated | $310,780 | 2021 |
| HTIC, INC. | Not stated | $310,438 | 2025 |
| CELL PRESERVATION SERVICES INC | Not stated | $310,376 | 2022 |
| CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE OF CASE WESTERN RESERVE UNIVERSITY | Not stated | $310,022 | 2025 |
| INDEE. INC. | Not stated | $309,636 | 2022 |
| YALE UNIV | Not stated | $309,386 | 2025 |
| ASPERO MEDICAL, INC. | Not stated | $309,337 | 2020 |
| ZEBRA BIOLOGICS INC | Not stated | $308,708 | 2021 |
| CHILDREN'S HOSPITAL CORPORATION, THE | Not stated | $308,220 | 2025 |
| UNITED BIOTHERAPEUTICS LLC | Not stated | $307,508 | 2025 |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | Not stated | $307,108 | 2025 |
| UNIVERSITY OF MIAMI | Not stated | $307,000 | 2021 |
| INVIZIX, INC. | Not stated | $306,872 | 2025 |
| DUPAGE MEDICAL TECHNOLOGY INC | Not stated | $306,867 | 2025 |
| WASHINGTON UNIVERSITY, THE | Not stated | $306,532 | 2025 |
| SYGNAMAP INC | Not stated | $306,500 | 2021 |
| SIRAJ THERAPEUTICS INC | Not stated | $306,100 | 2023 |
| CYPRESS BIOPHARMA, INC. | Not stated | $305,786 | 2025 |
| MAGURO SURGICAL INC | Not stated | $305,368 | 2025 |
| UNIVERSITY OF UTAH | Not stated | $305,000 | 2021 |
| IMMUNOWORK LLC | Not stated | $304,993 | 2025 |
| SYMBERIX, INC. | Not stated | $304,553 | 2022 |
| KITWARE INC | Not stated | $304,513 | 2024 |
| MYRACLE THERAPEUTICS INC | Not stated | $304,461 | 2024 |
| GENETOBE INC | Not stated | $303,746 | 2024 |
| LACTIGA US INC. | Not stated | $303,427 | 2025 |
| THE LELAND STANFORD JUNIOR UNIVERSITY | Not stated | $303,388 | 2010 |
| CONFOMRTRX INC | Not stated | $303,375 | 2023 |
| DANA-FARBER CANCER INSTITUTE, INC. | Not stated | $303,176 | 2025 |
| CHILDRENS HOSPITAL | Not stated | $302,610 | 2019 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES | Not stated | $302,470 | 2023 |
| THE REGENTS OF THE UNIVERSITY OF COLORADO | Not stated | $301,786 | 2025 |
| NORTHWESTERN UNIVERSITY | Not stated | $301,735 | 2021 |
| D BIOTHERAPEUTICS, LLC | Not stated | $301,488 | 2022 |
| S1P THERAPEUTICS INC. | Not stated | $301,373 | 2023 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | Not stated | $301,171 | 2018 |
| TRANSCHROMIX LLC | Not stated | $300,670 | 2023 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | Not stated | $300,638 | 2025 |
| ABALONE BIO, INC. | Not stated | $300,241 | 2021 |
| LUNG THERAPEUTICS, INC | Not stated | $300,228 | 2020 |
| KLEIN BUENDEL, INC. | Not stated | $300,172 | 2025 |
| UNIVERSITY OF TENNESSEE | Not stated | $300,007 | 2019 |
| AMIDEBIO, LLC | Not stated | $300,000 | 2021 |
| APT THERAPEUTICS, INC. | Not stated | $300,000 | 2020 |
| B2M MEDICAL INC | Not stated | $300,000 | 2022 |
| GLYCOMANTRA INC | Not stated | $300,000 | 2020 |
| HYDROCISION INC | Not stated | $300,000 | 2023 |
| MINUTIA INC | Not stated | $300,000 | 2021 |
| RECOMBINETICS INC | Not stated | $300,000 | 2019 |
| RESHAPE LIFESCIENCES INC | Not stated | $300,000 | 2022 |
| STEMBIOSYS INC. | Not stated | $300,000 | 2023 |
| THERATOME BIO, INC. | Not stated | $300,000 | 2019 |
| VIBRATO MEDICAL INC | Not stated | $300,000 | 2022 |
| HIBAR MICROSCIENCES, LLC | Not stated | $299,999 | 2023 |
| VIOCARE, INC. | Not stated | $299,997 | 2019 |
| DIATECH DIABETES, INC | Not stated | $299,989 | 2021 |
| SOMAGENICS INC | Not stated | $299,985 | 2019 |
| VISIONARY PHARMACEUTICALS, INC | Not stated | $299,985 | 2016 |
| D BIOTHERAPEUTICS, LLC | Not stated | $299,981 | 2022 |
| ASAKE BIOTECHNOLOGY, LLC | Not stated | $299,974 | 2021 |
| PROCYON TECHNOLOGIES LLC | Not stated | $299,968 | 2023 |
| GPER G-1 DEVELOPMENT GROUP LLC | Not stated | $299,952 | 2020 |
| RESILIO THERAPEUTICS LLC | Not stated | $299,934 | 2020 |
Recipient names as published by the California Grants Portal.
What comparable notices state
291 recordsStated ceilings on open records in the same industry.
Among open records stored under Health & Human Services, 291 of 887 state an award ceiling. Those that do run:
- 25th percentile$357,500
- Median$600,000
- 75th percentile$1,500,000
A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.
Who has won this programme before?
9106 awardsAwards under the same assistance listing, not under this notice.
9106 federal awards on file under assistance listing 93.847, the programme this notice is published under. These are not awards made under this notice — a listing covers every year the programme runs, and awards under an open notice do not exist yet.
- $440,444,754BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASONWA · FY2014
- $200,221,259RHO FEDERAL SYSTEMS DIVISION INCNC · FY2015
- $181,279,494UNIVERSITY OF SOUTH FLORIDAFL · FY2015
- $112,529,392GEORGE WASHINGTON UNIVERSITY (THE)MD · FY2001
- $82,457,560THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKNY · FY2022
Common questions
7 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- How much can one applicant receive?
- Up to $750,000 per recipient.
- How much funding is available in total?
- $4,800,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
- When is the application deadline?
- Feb 10, 2027.
- Who is eligible to apply?
- City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments.
- What can the funding be used for?
- digestive and liver diseases research, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
- Has this programme funded anyone before?
- 9106 prior awards are on file for this programme, made by National Institutes of Health. Recipients, amounts and fiscal years are listed on this page.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inWhat else is open
- Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)Closes Not statedAwards Not stated
- NIH Director's Transformative Research Award (R01 Clinical Trial Optional)Closes Not statedAwards Not stated
- NIH Director's Pioneer Award (DP1 Clinical Trial Optional)Closes Not statedAwards $700,000
- NIH Director's Early Independence Award (DP5 Clinical Trial Optional)Closes Not statedAwards $350,000
- NIH Director's New Innovator Award (DP2 Clinical Trial Optional)Closes Not statedAwards $475,000
- Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)Closes Not statedAwards Not stated
A listing names the programme; a notice names one round of it. These are other rounds open now, not other years of this one.
- Collaborative Awards to Support Microphysiological System Pilot Studies in Type 2 Diabetes Research (R21, Clinical Trial Not Allowed)Closes Not statedAwards Not stated
- Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)Closes Jan 7, 2028Awards up to $75,000
- NIH Research Project Grant (Parent R01 Clinical Trial Required)Closes Jan 7, 2028Awards Not stated
- Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)Closes May 7, 2028Awards Not stated
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)Closes Nov 6, 2026Awards Not stated
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)Closes Nov 9, 2026Awards Not stated
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.